Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05597878 · ClinicalTrials.gov registry record · Phase 2
Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy
A Phase 2 study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- Phase 2
- Development phase
- 58
- Enrollment target
NCT05597878 is a Phase 2 study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 58 participants.
The verdict
NCT05597878, a Phase 2 study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 58 participants
- Enrollment target
Study Summary
The objective of this study is to conduct a randomized clinical trial to evaluate an opioid versus an opioid-free pathway of perioperative use of ketamine, ketorolac, and IV acetaminophen followed by the postoperative use of ketorolac, and oral acetaminophen for pain associated with robotic-assisted radical prostatectomy. Escalation to use of opioid treatment for the opioid-free constituents will be available if needed.
Interventions
- DRUG Acetaminophen
- DRUG Ketamine
- DRUG Ketorolac
- DRUG Oxycodone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2023-04-18 |
| Est. Completion | 2026-02-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05597878
The ClinicalTrials.gov registry entry for NCT05597878 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Acetaminophen is the first listed.
NCT05597878 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05597878 about?
NCT05597878 is a clinical study titled "Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy". The objective of this study is to conduct a randomized clinical trial to evaluate an opioid versus an opioid-free pathway of perioperative use of ketamine, ketorolac, and IV acetaminophen followed by the postoperative use of ketorolac, and oral acetaminophen for pain associated with robotic-assisted...
What is the current status of trial NCT05597878?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 58 participants. The study started on 2023-04-18. Estimated completion is 2026-02-26.
What interventions are being tested in trial NCT05597878?
The interventions under investigation include: Acetaminophen (DRUG), Ketamine (DRUG), Ketorolac (DRUG), Oxycodone (DRUG).
Who is sponsoring clinical trial NCT05597878?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.